Aspira Women's Health

Aspira Women's Health is a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools. Their mission is to transform women's health by discovering, developing, and utilizing innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management, and improve gynecological health outcomes for women. Aspira has FDA-cleared products Ova1® and Overa® that detect the risk of ovarian malignancy in women with adnexal masses. Aspira also has a portfolio of blood tests called OvaSuiteSM, which includes Ova1Plus® and OvaWatch®, that help healthcare providers confidently develop a management plan for women with adnexal masses. Aspira's products are designed to stratify risk, facilitate early detection, and optimize treatment plans.

Aspira is dedicated to solving women's health issues for all ethnicities, stages, and ages. Their data-driven approach delivers solutions that help women take control of their gynecologic health and empower providers to deliver optimal care. Aspira has a Clinical Advisory Board made up of gynecologists who provide guidance on the company's research and product development. They are actively looking for physicians and clinical research groups interested in partnering with them to enroll patients in studies pertaining to women's gynecological health, starting with ovarian cancer, adnexal masses, and endometriosis. Aspira is committed to improving women's health through innovation and collaboration.

Aspira Women's Health offers a comprehensive benefits package to its employees. The benefits include a generous stock option plan, fast-track career growth potential, and a supportive environment that encourages collaboration and shared goals.

Aspira Women's Health is a bio-analytical based women's health company dedicated to transforming women's gynecologic health by discovering, developing, and utilizing innovative diagnostic and bio-analytical solutions. Their mission is to provide physicians with high-value tools to diagnose, treat, and improve health outcomes for women, with a specific focus on ovarian cancer and endometriosis. Aspira's data-driven approach aims to empower women to take control of their gynecologic health and enable providers to deliver optimal care.

Aspira Women's Health fosters a culture of collaboration and innovation, with a focus on improving women's health outcomes. They value diligence, caring, proactivity, disruption, and inspiration, creating a supportive environment where employees feel empowered to challenge the status quo and contribute to groundbreaking solutions. They promote a fast-track career growth potential and offer comprehensive benefits and a generous stock option plan to reward their employees for their contributions.

Aspira Women's Health is dedicated to improving gynecologic health outcomes for women of all races and ethnicities, regardless of their menopausal status. They are committed to solving women's health issues for all ethnicities, stages, and ages. Aspira actively works with patient advocacy organizations to increase awareness of ovarian cancer detection.